Salud

A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection

26 mayo 2024

0 Menos de un minuto

New England Journal of Medicine, Ahead of Print.

massmed: New England Journal of Medicine: Table of Contents

26 mayo 2024

0 Menos de un minuto